Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
BDBecton, Dickinson and Company logo

Becton, Dickinson and Company (BDX)

New York Stock Exchange · Currency in USD
$198.91 ▼ -1.51 (-0.75%)
At close: Oct 23, 4:00 PM ET. Market closed.
$198.91 ▲ +0.00 (+0.00%)
After hours: Oct 23, 4:18 PM ET

Summary

Previous Close
$200.42
Open
$199.18
Day's Range
$197.17 – $200.40
52 Week Range
$127.59 – $200.47
Volume
1,304,203
Avg. Volume
1,978,790
Market Cap
$54.18B
Beta (5Y Monthly)
0.28
PE Ratio (TTM)
59.91
EPS (TTM)
$3.42
Earnings Date
Nov 5, 2026
Forward Dividend & Yield
$4.20 (2.11%)
Ex-Dividend Date
Sep 9, 2026
1y Target Est
$188.33

Profile: Becton, Dickinson and Company

Sector
Healthcare
Industry
Medical - Instruments & Supplies
Full-time employees
72,000
CEO
Thomas E. Polen Jr.
Website
bd.com

Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products. Its extensive customer base comprises healthcare providers, clinical institutions, medical researchers, pharmaceutical firms, and the general public around the world.

Earnings

Next report: Thu, Nov 5, 2026
EPS estimate $4.07 · Revenue est. $5.11B
DateEst.Actual
Aug 6, 2026$3.14$3.23Beat
May 7, 2026$2.78$2.90Beat
Feb 9, 2026$2.21$2.91Beat
Nov 6, 2025$3.92$3.96Beat
Aug 7, 2025$3.40$3.68Beat
May 1, 2025$3.28$3.35Beat

Analyst view

Consensus price target
$188.33 ▼ -5.3%
Range $165.00 – $210.00
Rating: Hold
Buy 47% · Hold 50% · Sell 3%

Get free alerts on BDX and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.